Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.19p

Change Today:

0.050p
52 Week High: 3.42
52 Week Low: 0.85

Currency: UK Pounds
Shares Issued: 416.44m
Volume: 429,497

Market Cap: £9.12m
RiskGrade: 328

ShareCast News

ImmuPharma pleased with Lupuzor open-label study...	28-Jun-2019	ShareCast
Immupharma raises ?2.66m from subscription agree...	26-Jun-2019	ShareCast
ImmuPharma seeks route forward for lupus treatme...	24-May-2019	ShareCast
ImmuPharma struggles to convince investors in la...	14-Mar-2019	ShareCast
ImmuPharma upbeat on product from subsidiary Ureka	26-Feb-2019	ShareCast
ImmuPharma and Incanthera extend exclusivity per...	31-Dec-2018	ShareCast
Immupharma plots patient recruitment for Lupzor ...	07-Dec-2018	ShareCast
ImmuPharma still banking on Lupuzor even after f...	26-Sep-2018	ShareCast
Wednesday broker round-up	26-Sep-2018	ShareCast
Sunday share tips: Immupharma, PCF Bank	09-Sep-2018	ShareCast
Immupharma to make 'blockbuster' lupus treatment...	07-Sep-2018	ShareCast
Immupharma finds potential alternate indications...	14-Jun-2018	ShareCast
ImmuPharma impresses with mixed data from lupus ...	29-May-2018	ShareCast
ImmuPharma tanks after disappointment with lupus...	17-Apr-2018	ShareCast
Friday broker round-up	23-Mar-2018	ShareCast
ImmuPharma anticipating latest Lupuzor test resu...	23-Mar-2018	ShareCast
Tuesday broker round-up	24-Jan-2018	ShareCast
ImmuPharma raises £10m following investor demans	24-Jan-2018	ShareCast
Thrusday broker round-up	18-Jan-2018	ShareCast
ImmuPharma makes progress with Phase III trial o...	02-Nov-2017	ShareCast
ImmuPharma completes sharing agreement with Lans...	04-Oct-2017	ShareCast
ImmuPharma issues another update on Lupuzor	26-Sep-2017	ShareCast
Immupharma pleased with Lupuzor trial progress	30-Jun-2017	ShareCast
ImmuPharma trial of Lupuzor continuing smoothly	25-Jan-2017	ShareCast
ImmuPharma completes patient recruitment in Lupu...	22-Dec-2016	ShareCast
ImmuPharma makes positive progress in Lupuzor ...	14-Sep-2016	ShareCast
ImmuPharma doses first patients in the US	15-Feb-2016	ShareCast
ImmuPharma to raise £7.5m for 'blockbuster' drug	05-Feb-2016	ShareCast
ImmuPharma's Lupuzor trial on track for 2017 com...	04-Nov-2015	ShareCast
Immupharma raises £3.4m as it gears up for Lupuz...	21-Oct-2014	ShareCast
Sunday share tips: BG Group, Genel Energy, Palac...	05-Oct-2014	ShareCast
Immupharma gains new patents for Nucant treatmen...	16-Jun-2014	ShareCast
ImmuPharma's patient approach disappoints	21-May-2014	ShareCast
ImmuPharma reports half-year loss	27-Sep-2013	ShareCast
Immupharma progresses with cancer treatment tria...	13-Aug-2013	ShareCast
ImmuPharma non-exec reduces stake	28-Jan-2013	ShareCast
Immupharma reports success of partner's latest L...	28-Jan-2013	ShareCast
ImmuPharma's losses grow in 2011	27-Mar-2012	ShareCast
SABMiller exec buys a round	24-Jan-2012	ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Immupharma Market Data

Currency	UK Pounds
Share Price	2.19p
Change Today	0.050p
% Change	2.34 %
52 Week High	3.42
52 Week Low	0.85
Volume	429,497
Shares Issued	416.44m
Market Cap	£9.12m
RiskGrade	328